About Altasciences

  • About Altasciences
  • Altasciences' Facilities: Moving in Unison

    Medhealth Outlook: Altasciences—The Most Powerful and Integrated CRO/CDMO Solution

    Thank You, From Altasciences

    On June 15, our team took time to celebrate Altasciences, and how we move in unison to help you bring better drugs to the people who need them, faster.

    Every day, and especially on Altasciences Day, I feel a great sense of appreciation and gratitude—for our talented experts who help build our business, as well as for YOUR ongoing trust and partnership.

    Together, we change lives. And I can’t thank you enough for taking us along on your innovative, life-saving journey.

    It is with pride that I share with you a photo album from our Altasciences Day celebrations.

    See the photo album.

    Thank you again,

    Chris Perkin's signature

    Chris Perkin
    CEO, Altasciences

    Since 2004, the average cost of bringing a new drug to market has increased from $800 million to about $2.6 billion, without, for the most part, shorter development time

    Volume On—Latest Scientific Audiobook Releases

    Listen to the Latest Scientific Audiobook Releases

    Delve deeper into the critical processes behind early phase drug development with audio versions of eBooks and The Altascientist, written by our experts with you in mind:

    The Altascientist Issue 30

    The Altascientist: Issue 30 — The Evolution and Advancement of LCMS in Drug Development
    Learn how the latest LC-MS advancements ensure accurate and precise data delivery in your drug development program.
    Listen to the audiobook >>>

    The Altascientist issue 28

    The Altascientist: Issue 28 — Applications of Liquid-Filled, Hard-Shell Capsules in Drug Development
    Discover the advantages that liquid-filled, hard-shell capsules offer for the formulation of highly potent APIs and drugs that benefit from slow or extended release.
    Listen to the audiobook >>>

    The Altascientist Issue 29

    The Altascientist: Issue 29 — Building Your Early Phase Clinical Trial Data, From Protocol to Regulatory Submission
    Explore best practices and approaches for mitigating challenges when it comes to your data and bringing your drug to market.
    Listen to the audiobook >>>

    FIH eBook

    eBook: First-in-Human Solution for Small and Large Molecules
    Uncover Altasciences' comprehensive, multi-service solution for your first-in-human trials—beyond the clinic.
    Listen to the audiobook >>>

     

    What Drug Developers are Saying About Altasciences

    DON'T JUST TAKE OUR WORD FOR IT...

    Altasciences has leading expertise in the formulation and manufacturing of highly potent APIs and controlled substances, which often present unique complexities.

    When Emyria presented us with the challenge of creating a cannabidiol (CBD) formulation from scratch for a new over-the-counter product in a very short time period, they trusted that we had the skills to successfully deliver.

    Here’s what Emyria had to say about why they chose Altasciences and their experience:

    "As a young company new to drug development, we chose to work with Altasciences because of their experience and reputation for excellence.

    Altasciences has been a great partner for us in the early drug development phase; they helped us navigate the difficult path from formulation through to clinical manufacturing. In one short year, we have gone from idea through to Phase III clinical trials. They operate in a fully qualified, FDA-inspected cGMP facility. Their team meets with us weekly to keep us informed, and is always approachable and available for questions, comments, or concerns. They have shown a high degree of patience and flexibility with our changing needs.

    We enjoy working with the team at Altasciences and wouldn't hesitate to recommend them."

    Tracie Ernenwein

    Speak with one of our experts today for all your drug development needs― from early prototype formulation, to preclinical testing and clinical trial supply, all the way through to commercial manufacturing.

    Related Resources:

    Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

    Altasciences’ Proactive Drug Development Solution—Small Molecules

    The process from lead molecule identification to completion of a first‑in‑human trial can be long and complicated. But with Altasciences’ Proactive Drug Development solution, your timelines can be reduced by up to 40%. Your entire program will be managed by one organization and overseen by a single, cross-functional program manager to quickly and seamlessly advance your molecule from preclinical testing to first‑in‑human clinical trials, and beyond—helping you get your medicines to the people who need them, faster.

    Learn more by downloading our eBook.

     

    Selecting the Right Bioanalytical Platform for Your Molecule

    Discover a Simpler Way to Drug Development Success

     

    Altasciences keeps you on track, milestone to milestone.

    Avoid delays caused by operational roadblocks, miscommunications, and lack of data sharing. 

    Discover a simpler way to drug development success and how Altasciences’ integrated end-to-end CRO/CDMO solutions can safely move your molecule seamlessly from one phase to the next, and to market faster.

    Start Watching!

    Got 5 more minutes? Check out: 


    Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.

    .custom-column-left-text { float: left; width: 50%; padding-right: 10px; } .custom-column-right-text { float: right; width: 45%; text-align:center; } @media only screen and (max-width: 600px) { .custom-column-left-text, .custom-column-right-text, .custom-column-flc-ebook-text { float:none; width:80%; margin:0 auto; } }

    Marie-Hélène has been a leader in the drug development industry for close to 20 years.

    Subscribe to About Altasciences